Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.92 USD | +1.18% | -6.78% | -11.92% |
May. 09 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
May. 08 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.